Rua Bioscience announces an extension to the timetable for its current pro rata rights offer. The closing date has been extended from Tuesday, November 26 2024, to the close of business on Monday, December 2, 2024.
This extention supports our recognition of the significant number of Tairāwhiti shareholders who are supporting the Toitū Te Tiriti activations across the country as the growing hikoi makes its way to parliament.
Rua Bioscience notes that while the closing date for existing shareholders to partiticipate in the offer has been extended, for eligible shareholders who wish to sell their entitlements, rights trading closes tomorrow (20 November) at close of trading on the NZX Main Board. The important new dates as a consequence of the extension are as follows:
Closing Date of the Offer
(being the date by which applications and payment must be received)
Monday,2 December 2024
Announcement of Results of the Offer
Wednesday, 4 December 2024
Issue Date
(for the allotment and issue of the New Shares)
Friday, 6 December 2024
Quotation of New Shares on NZX Main Board
Friday, 6 December 2024
For further information, please visit our website at www.ruabio.com.
We appreciate the ongoing support of our shareholders as we continue to drive positive change in the medicinal cannabis industry.
ENDS
The person who authorised this announcement:
Paul Naske
Chief Executive Officer
[email protected]
+64 21 445154
Growth-stage venture market at its most 'investor friendly' since 2013 - Icehouse.
Private equity, private credit and long short equity funds are on offer.
Genesis argues it is undervalued; at least one analyst agrees.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details